Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Receives More than 100 Systems Orders Tied to Stimulus Programs

NEW YORK (GenomeWeb News) – Bruker today said that it has already received more than 100 systems orders associated with various global stimulus funding programs.

The firm said that all five of its operating divisions have received stimulus orders for instruments such as mass spectrometry, NMR, pre-clinical MRI, and X-ray. Bruker estimated the average selling prices of these orders were greater than $500,000 per system — and the total amount of stimulus orders it received in the second half of 2009 exceeded $70 million.

The Billerica, Mass.-based firm said that revenues from these orders would be recorded primarily in 2010 and into the first half of 2011. It also expects to receive additional orders from global stimulus programs during this year.

In September, Bruker said that global stimulus programs could contribute 5 percent — roughly $50 million — or greater revenue growth its core scientific business instruments business in 2010.

In early Thursday trade on the Nasdaq, shares of Bruker were up 2 percent at $13.35.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.